BUDGET IMPACT ANALYSIS OF INDACATEROL/GLYCOPYRRONIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN COLOMBIA

被引：0
|
作者：
Patino, A. [1 ]
Karpf, E. [1 ]
Londono, D. [2 ]
机构：
[1] Novartis Colombia, Bogota, Colombia
[2] Fdn Santa Fe Bogota, Bogota, Colombia
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2662
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS6
引用
收藏
页码：A888 / A888
页数：1
相关论文
共 50 条
  • [41] Comparative effectiveness of umeclidinium/ vilanterol versus indacaterol/glycopyrronium on acute exacerbations in patients with chronic obstructive pulmonary disease in England
    Requena, G.
    Czira, A.
    Banks, V
    Wood, R.
    Tritton, T.
    Castillo, C.
    Yeap, J.
    Wild, R.
    Compton, C.
    Duarte, M.
    Rothnie, K.
    Herth, F.
    Ismaila, A.
    PNEUMOLOGIE, 2023, 77 : S58 - S59
  • [42] Comparative effectiveness of umeclidinium/vilanterol versus indacaterol/glycopyrronium on acute exacerbations in patients with chronic obstructive pulmonary disease in England
    Requena, G.
    Czira, A.
    Banks, V.
    Wood, R.
    Tritton, T.
    Castillo, C.
    Yeap, J.
    Wild, R.
    Compton, C. Chris
    Duarte, M.
    Rothnie, K.
    Ismaila, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [43] Indacaterol for Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis
    Chung, Vincent C. H.
    Ma, Polly H. X.
    Hui, David S. C.
    Tam, Wilson W. S.
    Tang, Jin Ling
    PLOS ONE, 2013, 8 (08):
  • [44] HEALTH ECONOMIC EVALUATION AND BUDGET IMPACT ANALYSIS OF POPULATION-BASED SCREENING FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN CHINA
    Fan, Y.
    Chen, Q.
    Chen, S.
    VALUE IN HEALTH, 2024, 27 (12)
  • [45] Depression and chronic obstructive pulmonary disease (COPD). Impact on survival
    Stage, KB
    Middelboe, T
    Pisinger, C
    ACTA PSYCHIATRICA SCANDINAVICA, 2005, 111 (04) : 320 - 323
  • [46] Indacaterol/glycopyrronium affects lung function and cardiovascular events in patients with chronic obstructive pulmonary diseases: A meta-analysis
    Zhang, Qinxia
    Zhang, Haifu
    Wang, Jianjun
    Ruan, Zhaoyang
    Dai, Yifan
    Xia, Zehai
    Lv, Qun
    HEART & LUNG, 2021, 50 (04): : 532 - 541
  • [47] Impact of chronic obstructive pulmonary disease (COPD) on attention functions
    Klein, M.
    Gauggel, S.
    Sachs, G.
    Pohl, W.
    RESPIRATORY MEDICINE, 2010, 104 (01) : 52 - 60
  • [48] BUDGET IMPACT ANALYSIS OF TIOTROPIUM BROMIDE VERSUS IPRATROPIUM BROMIDE ON THE TOP OF STANDARD THERAPY IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN RUSSIAN FEDERATION
    Kulikov, A.
    Komarov, I
    VALUE IN HEALTH, 2012, 15 (04) : A53 - A53
  • [49] ECONOMIC EVALUATION OF INDACATEROL IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FROM THE PUBLIC PAYER PERSPECTIVE IN BRAZIL
    Suzuki, C.
    Silva, N. L.
    VALUE IN HEALTH, 2011, 14 (07) : A493 - A493
  • [50] Improvement in health status of Chronic Obstructive Pulmonary Disease (COPD) patients with indacaterol/glycopyrronium therapy: Real-world evidence from an observational study in Ireland.
    Masterson, D.
    Bolger, K.
    Raza, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S282 - S282
12345